Literature DB >> 19107536

Imaging E-selectin expression following traumatic brain injury in the rat using a targeted USPIO contrast agent.

Catherine Chapon1, Florence Franconi, Franck Lacoeuille, François Hindré, Patrick Saulnier, Jean-Pierre Benoit, Jean-Jacques Le Jeune, Laurent Lemaire.   

Abstract

INTRODUCTION: The aim of this work was to map E-selectin expression in a traumatic brain injury model using a newly-designed MR contrast agent. Iron cores, responsible for susceptibility effects and therefore used as T2* contrast agents, need to be coated in order to be stabilized and need to be targeted to be useful.
METHODS: We have designed a molecule coating composed, at one end, of bisphosphonate to ensure anchorage of the coating on the iron core and, at the other end, of Fukuda's defined heptapeptide known to target selectin binding sites.
CONCLUSION: The synthesized nanoparticles were able to non-invasively target the traumatic brain lesion, inducing a specific T2* decrease of about 25% up to at least 70 min post-injection of the targeted contrast agent.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19107536      PMCID: PMC3185927          DOI: 10.1007/s10334-008-0161-z

Source DB:  PubMed          Journal:  MAGMA        ISSN: 0968-5243            Impact factor:   2.310


  51 in total

1.  Effects of diffusion anisotropy on lesion delineation in a rat model of cerebral ischemia.

Authors:  M F Lythgoe; A L Busza; F Calamante; C H Sotak; M D King; A C Bingham; S R Williams; D G Gadian
Journal:  Magn Reson Med       Date:  1997-10       Impact factor: 4.668

2.  Magnetic resonance imaging of inflammation with a specific selectin-targeted contrast agent.

Authors:  Sébastien Boutry; Carmen Burtea; Sophie Laurent; Gérard Toubeau; Luce Vander Elst; Robert N Muller
Journal:  Magn Reson Med       Date:  2005-04       Impact factor: 4.668

3.  [Serious brain injury and public health, epidemiologic and financial considerations, comprehensive management and care].

Authors:  J-F Mathé; I Richard; J Rome
Journal:  Ann Fr Anesth Reanim       Date:  2005-06

4.  Targeted ultrasound contrast agents: in vitro assessment of endothelial dysfunction and multi-targeting to ICAM-1 and sialyl Lewisx.

Authors:  Gregory E R Weller; Flordeliza S Villanueva; Eric M Tom; William R Wagner
Journal:  Biotechnol Bioeng       Date:  2005-12-20       Impact factor: 4.530

5.  Electrokinetic properties of noncharged lipid nanocapsules: influence of the dipolar distribution at the interface.

Authors:  Arnaud Vonarbourg; Patrick Saulnier; Catherine Passirani; Jean-Pierre Benoit
Journal:  Electrophoresis       Date:  2005-06       Impact factor: 3.535

6.  ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex.

Authors:  M L Phillips; E Nudelman; F C Gaeta; M Perez; A K Singhal; S Hakomori; J C Paulson
Journal:  Science       Date:  1990-11-23       Impact factor: 47.728

7.  Peptides which bind to E-selectin and block neutrophil adhesion.

Authors:  C L Martens; S E Cwirla; R Y Lee; E Whitehorn; E Y Chen; A Bakker; E L Martin; C Wagstrom; P Gopalan; C W Smith
Journal:  J Biol Chem       Date:  1995-09-08       Impact factor: 5.157

8.  MR molecular imaging of early endothelial activation in focal ischemia.

Authors:  Philip A Barber; Tadeusz Foniok; David Kirk; Alastair M Buchan; Sophie Laurent; Sébastien Boutry; Robert N Muller; Lisa Hoyte; Boguslaw Tomanek; Ursula I Tuor
Journal:  Ann Neurol       Date:  2004-07       Impact factor: 10.422

9.  MRI detection of early endothelial activation in brain inflammation.

Authors:  Nicola R Sibson; Andrew M Blamire; Martine Bernades-Silva; Sophie Laurent; Sébastien Boutry; Robert N Muller; Peter Styles; Daniel C Anthony
Journal:  Magn Reson Med       Date:  2004-02       Impact factor: 4.668

10.  Noninvasive imaging of E-selectin expression by activated endothelium in urate crystal-induced arthritis.

Authors:  P T Chapman; F Jamar; A A Harrison; R M Binns; A M Peters; D O Haskard
Journal:  Arthritis Rheum       Date:  1994-12
View more
  6 in total

Review 1.  Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases.

Authors:  Howard E Gendelman; Vellareddy Anantharam; Tatiana Bronich; Shivani Ghaisas; Huajun Jin; Anumantha G Kanthasamy; Xinming Liu; JoEllyn McMillan; R Lee Mosley; Balaji Narasimhan; Surya K Mallapragada
Journal:  Nanomedicine       Date:  2015-01-31       Impact factor: 5.307

2.  Advances in MRI-Based Detection of Cerebrovascular Changes after Experimental Traumatic Brain Injury.

Authors:  Rick M Dijkhuizen
Journal:  Transl Stroke Res       Date:  2011-11-12       Impact factor: 6.829

3.  Targeted Nanocarriers for Imaging and Therapy of Vascular Inflammation.

Authors:  Ann-Marie Chacko; Elizabeth D Hood; Blaine J Zern; Vladimir R Muzykantov
Journal:  Curr Opin Colloid Interface Sci       Date:  2011-06       Impact factor: 6.448

4.  Multicolor fluorescence imaging of traumatic brain injury in a cryolesion mouse model.

Authors:  Bryan A Smith; Bang-Wen Xie; Ermond R van Beek; Ivo Que; Vicky Blankevoort; Shuzhang Xiao; Erin L Cole; Mathias Hoehn; Eric L Kaijzel; Clemens W G M Löwik; Bradley D Smith
Journal:  ACS Chem Neurosci       Date:  2012-04-07       Impact factor: 4.418

Review 5.  Molecular magnetic resonance imaging of brain-immune interactions.

Authors:  Maxime Gauberti; Axel Montagne; Aurélien Quenault; Denis Vivien
Journal:  Front Cell Neurosci       Date:  2014-11-27       Impact factor: 5.505

Review 6.  Targeting Selectins Mediated Biological Activities With Multivalent Probes.

Authors:  Deepak Ganesh; Prashant Jain; Chethan Devanur Shanthamurthy; Suraj Toraskar; Raghavendra Kikkeri
Journal:  Front Chem       Date:  2021-12-03       Impact factor: 5.221

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.